Sen. Steve Daines has secured appointments to both the Senate Finance and Appropriations committees, a dual assignment that gives Montana extraordinary influence over federal spending and taxation policy. The placement required a waiver from Senate Republican conference rules and marks the first time in 75 years that a single senator has held both positions simultaneously.
The two committees rank among the Senate’s most powerful, controlling oversight of the vast majority of federal revenues and expenditures. Finance handles prescription drug prices, Medicare, Medicaid, taxes, and trade policy, while Appropriations determines how billions in federal dollars flow across the government. Daines now has a vote on every dollar the federal government raises and spends.
Rare Authority and Political Advantage
Robert Saldin, a University of Montana political science professor, described the assignments as exceptionally consequential. “Those are arguably two of the most consequential committees in the Senate, and he’s on both of them,” he said.
The dual placement carries significant political benefits. David Parker, an associate professor of political science at Montana State University, noted that the visibility and influence attached to the committees enhance Daines’ standing with donors. “I think the number one way it helps is it raises his fundraising profile, which will help deter challengers from entering the race,” Parker said.
Sen. James Lankford of Oklahoma received the same waiver, making both men rare exceptions to standard Senate practice. Daines joins the Appropriations Committee alongside fellow Montana senator Jon Tester, a Democrat who has held that seat since 2015. Tester previously benefited from his position on the Banking Committee, which attracted substantial contributions from the securities and investment industries—totaling $1.5 million between 2015 and 2019.
Focus on Prescription Drug Costs
Senate Finance Committee chairman Chuck Grassley, an Iowa Republican, outlined priorities in a November 26 floor speech that placed prescription drug and health care costs at the forefront of the committee’s agenda this year. The timing reflects a growing policy concern: per capita spending on prescription drugs has doubled over the past two decades, and roughly one quarter of Americans on fixed incomes report difficulty affording their medications.
Price-fixing allegations against pharmaceutical manufacturers have drawn sustained scrutiny. Multiple state attorneys general have filed lawsuits against generic drug makers for allegedly manipulating prices, bringing the issue to the forefront of legislative attention.
Daines outlined his legislative priorities as balanced budgets, responsible government spending, lower taxes, active management of public lands and resources, and fulfilling federal obligations to Montana’s tribes. His positions on Finance and Appropriations place him in position to shape policy across all these domains.
Daines recently concluded two decades leading the Senate National Parks Committee, and he has pressed the U.S. Trade Representative to lift Cold War-era restrictions affecting Montana’s palladium industry. The new committee assignments expand his leverage on issues ranging from infrastructure spending to natural resource management.
The committee seats underscore Montana’s growing clout in a Republican-controlled Senate, where Daines ranks among leadership and maintains influence over fiscal policy decisions that affect states nationwide.
